You cannot register for this webinar

April DMPK Webinar: What’s New with the ICH M12 Guidance on Drug-Drug Interactions? This webinar will discuss changes in regulatory guidance about predicting the risk of drug-drug interactions (DDIs), as codified in ICH M12 compared with previous FDA and EMA guidance.​ Agenda: - The regulatory landscape of in-vitro DDI assays ​ - New aspects of testing requirements according to ICH M12​ - Study designs and workflows​ - Clinical DDI risk prediction​